Oncogenic truncations of ASXL1 enhance a motif for BRD4 ET-domain binding
A. E. Burgess, T. Kleffmann, P. D. Mace
This study identifies a molecular mechanism by which ASXL1 truncations enhance BRD4 binding through an ET-domain motif, potentially altering transcriptional regulation and offering therapeutic insights.
bioRxiv · Jul 15, 2021Biochemistry